June 27, 2026 04:39 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Fresh paper leak rocks India: Maharashtra TET postponed a day before exam, over 4 lakh aspirants affected | Pune fort murder case: Siya Goyal's brother says family would have called off marriage if she had objected | Donald Trump gets a road named after him in India, says 'Thank You!' | Fresh setback for Gautam Adani? US judge asks DoJ to justify dropping criminal charges | Ram Mandir Trust chief Champat Rai resigns as alleged donation siphoning row escalates | Ram Mandir fund row deepens: 8 arrested days after BJP called allegations 'false narrative' | 'Who tied the hands of CBI?': Calcutta HC on RG Kar case; victim's mother, now BJP MLA, says she is 'deeply disturbed' | Construction comes to a standstill at nearly 700 Kolkata projects after Taratala warehouse tragedy kills 15 | World Cup shocker! Ecuador stun Germany 2-1, storm into Round of 32 | Iran-US conflict: Cargo vessel hit near Strait of Hormuz, UN agency pauses evacuation operations
Covid-19
NDMC worker sanitises Indian Parliament (Image Credit: UNI)

India adds close to 98,000 Covid-19 cases in 24 hours, tally crosses 51-lakh mark

| @indiablooms | Sep 17, 2020, at 04:10 pm

New Delhi/IBNS: The total number of Novel Coronavirus cases in India on Thursday crossed the 51-lakh mark as the country of 1.3 billion people reported a record spike in Covid-19 cases by adding 97,894 fresh infections in the last 24 hours.

With the new cases, India's Covid-19 tally has touched 51,18,253.

83,198 Covid-19 patients have so far succumbed to the virus with 1,132 people dying from the disease in the last 24 hours.

Meanwhile, the Serum Institute of India (SII) has got the nod of the Drug Controller General of India (DCGI) to resume the phase two and three trials for Covid-19 vaccine, which has been developed by pharmaceutical giant AstraZeneca and Oxford University.

The Oxford vaccine trial was first halted by AstraZeneca after a suspected serious adverse reaction was seen in a participant in the United Kingdom last week.

Following the development, the SII had also halted the vaccine trials in the country.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.